Cardiomyopathies

"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Descriptor ID	D009202
MeSH Number(s)	C14.280.238
Concept/Terms	Cardiomyopathies Cardiomyopathies Cardiomyopathy Myocardial Diseases Disease, Myocardial Diseases, Myocardial Myocardial Disease Myocardiopathies Myocardiopathy Cardiomyopathies, Secondary Cardiomyopathies, Secondary Cardiomyopathy, Secondary Secondary Cardiomyopathies Secondary Cardiomyopathy Secondary Myocardial Diseases Disease, Secondary Myocardial Diseases, Secondary Myocardial Myocardial Disease, Secondary Secondary Myocardial Disease Myocardial Diseases, Secondary Cardiomyopathies, Primary Cardiomyopathies, Primary Cardiomyopathy, Primary Primary Cardiomyopathies Primary Cardiomyopathy Primary Myocardial Diseases Myocardial Diseases, Primary Disease, Primary Myocardial Diseases, Primary Myocardial Myocardial Disease, Primary Primary Myocardial Disease

Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Cardiomyopathies [C14.280.238]

Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiomyopathies" by people in this website by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.

Bar chart showing 180 publications over 28 distinct years, with a maximum of 15 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
1998	1	1	2
2000	0	2	2
2002	1	2	3
2003	1	3	4
2004	3	1	4
2005	4	2	6
2006	2	3	5
2007	6	1	7
2008	5	4	9
2009	2	2	4
2010	5	1	6
2011	8	2	10
2012	8	2	10
2013	2	1	3
2014	7	1	8
2015	9	0	9
2016	10	0	10
2017	9	1	10
2018	8	0	8
2019	3	2	5
2020	12	3	15
2021	8	1	9
2022	9	0	9
2023	8	1	9
2024	7	0	7
2025	3	1	4

Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.

Mellerio JE, Pillay EI, Sollesta K, Thiel KE, Zimmerman G, McGrath JA, Martinez AE, Jeffs E. Milestone events in recessive dystrophic epidermolysis bullosa: findings of the PEBLES study. Clin Exp Dermatol. 2025 May 23; 50(6):1125-1131.

View in: PubMed
Pender A, Lewis-Owona J, Ekiyoyo A, Stoddard M. Echocardiography and Heart Failure: An Echocardiographic Decision Aid for the Diagnosis and Management of Cardiomyopathies. Curr Cardiol Rep. 2025 Feb 28; 27(1):64.

View in: PubMed
Choi JC. Perinuclear organelle trauma at the nexus of cardiomyopathy pathogenesis arising from loss of function LMNA mutation. Nucleus. 2025 Dec; 16(1):2449500.

View in: PubMed
Rahimov D, Yan VZ, Ahmad D, Nasher N, Tatum R, Im M, Storozynsky E, Rame JE, Rajagopal K, Entwistle JW, Massey HT, Tchantchaleishvili V. Characteristics and outcomes of cardiac amyloid disease after heart transplantation: A systematic review and meta-analysis. Transplant Rev (Orlando). 2025 Apr; 39(2):100908.

View in: PubMed
Qu HQ, Delfiner MS, Gangireddy C, Vaidya A, Nguyen K, Whitman IR, Wang J, Song J, Bristow MR, McTiernan CF, Gerhard GS, Hakonarson H, Feldman AM. Rare variants in cardiomyopathy genes predispose to cardiac injury in severe COVID-19 patients of African or Hispanic ancestry. J Mol Med (Berl). 2025 Feb; 103(2):175-185.

View in: PubMed
Shahid M, Ibrahim R, Ulhaque T, Nhat H, Sainbayar E, Lee K, Mamas MA. Peripartum Cardiomyopathy and Social Vulnerability: An Epidemiological Analysis of Mortality Outcomes. J Am Heart Assoc. 2024 Nov 05; 13(21):e034825.

View in: PubMed
Robbins LS, Szychowski JM, Nassel A, Bansal A, Oben AG, Armour EK, Walker Z, Rajapreyar IN, Wingate M, Tita AT, Sinkey RG. Social Vulnerability May Underlie Racial Disparities in Peripartum Cardiomyopathy Outcomes. Ethn Dis. 2024 Aug; 34(3):173-178.

View in: PubMed
Sikder K, Phillips E, Zhong Z, Wang N, Saunders J, Mothy D, Kossenkov A, Schneider T, Nichtova Z, Csordas G, Margulies KB, Choi JC. Perinuclear damage from nuclear envelope deterioration elicits stress responses that contribute to LMNA cardiomyopathy. Sci Adv. 2024 05 10; 10(19):eadh0798.

View in: PubMed
Kowey PR, Olleik FM. Class IC Drugs in Cardiomyopathy: Keeping an Open Mind. JACC Clin Electrophysiol. 2024 May; 10(5):854-856.

View in: PubMed
Tomer O, Horowitz-Cederboim S, Rivkin D, Meiner V, Gollob MH, Zwas DR, Durst R, Shauer A. Variable clinical expression of a novel FLNC truncating variant in a large family. Int J Cardiol. 2024 Apr 15; 401:131849.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement